Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
6(66.7%)
Phase 3
2(22.2%)
Phase 2
1(11.1%)
9Total
N/A(6)
Phase 3(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)